Peloton Names Ex-Medivation Executive Hirmand Chief Medical Officer

Xconomy Texas — 

Cancer drug developer Peloton Therapeutics has appointed Mohammad Hirmand to the position of chief medical officer. He will start his new role at the Dallas-based company on May 1. Hirmand most recently served as chief medical officer of San Francisco-based Medivation, which Pfizer (NYSE: PFE) acquired last year in a $14 billion deal.